Similar articles

• Systemic toxicity with cyclopentolate eye drops.

  Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK. Bhatia SS, et al. Indian Pediatr. 2000 Mar;37(3):329-31. Indian Pediatr. 2000. PMID: 10750080 No abstract available.
• Mydriatic and cycloplegic drugs: a review of ocular and systemic complications.

  Rengstorff RH, Doughty CB. Rengstorff RH, et al. Am J Optom Physiol Opt. 1982 Feb;59(2):162-77. Am J Optom Physiol Opt. 1982. PMID: 7039329 Review.
• Contact allergy to atropine and other mydriatic agents in eye drops.

  Decraene T, Goossens A. Decraene T, et al. Contact Dermatitis. 2001 Nov;45(5):309-10. doi: 10.1034/j.1600-0536.2001.450519.x. Contact Dermatitis. 2001. PMID: 11722501 No abstract available.
• Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study.

  van Minderhout HM, Joosse MV, Grootendorst DC, Schalij-Delfos NE. van Minderhout HM, et al. BMJ Open. 2015 Dec 23;5(12):e008798. doi: 10.1136/bmjopen-2015-008798. BMJ Open. 2015. PMID: 26700273 Free PMC article.
• Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions.

  Jones LW, Hodes DT. Jones LW, et al. Ophthalmic Physiol Opt. 1991 Jan;11(1):16-21. Ophthalmic Physiol Opt. 1991. PMID: 2034449 Review.